Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies-Reference-Cited by-同舟云学术

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies

Published:2015-03-19 Issue:3 Volume:10 Page:e0119771
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bhutani Isha,Loharch Saurabh,Gupta Pawan,Madathil Rethi,Parkesh Raman

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference98 articles.

1. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance;A Wright;Lancet,2009

2. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture;J Daniel;J Bacteriol,2004

3. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen;C Deb;PLoS One,2009

4. Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection;P Seiler;J Infect Dis,2003

5. Tuberculosis: a global overview of the situation today;P Sudre;Bull World Health Organ,1992

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DprE1 and Ddn as promising therapeutic targets in the development of novel anti-tuberculosis nitroaromatic drugs;European Journal of Medicinal Chemistry;2024-08

2. Unveiling DprE1 as a Key Target in the Fight against Tuberculosis: Insights and Perspectives on Developing Novel Antimicrobial Agents;BioMed;2024-07-25

3. Modulators targeting protein-protein interactions in Mycobacterium tuberculosis;Microbiological Research;2024-07

4. Recent advances in the development of DprE1 inhibitors using AI/CADD approaches;Drug Discovery Today;2024-06

5. Targeting polyketide synthase 13 for the treatment of tuberculosis;European Journal of Medicinal Chemistry;2023-11